Amina J. Egwiekhor

Amina J. Egwiekhor

Auto-generated profile, based on publicly available information

Amina J. Egwiekhor

University Hospitals of Cleveland, Cleveland, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2020 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
PTPauline Terebuh
Pauline Terebuh
AEAmina J. Egwiekhor
Amina J. Egwiekhor
HGHeidi L. Gullett
Heidi L. Gullett
AFAdeola O. Fakolade
Adeola O. Fakolade
JMJill E. Miracle
Jill E. Miracle
TATerrence Allan
Terrence Allan
Background: Clusters of COVID‐19 cases amplify the pandemic and are critical targets for intervention, but comprehensive cluster‐level data are not collected systematically by federal or most state public health entities. This analysis characterizes COVID‐19 clusters among vulnerable populations housed in congregate living settings across an entire community and describes early mitigation efforts.Methods: The Cuyahoga County Board of Health identified and interviewed COVID‐19 cases and exposed contacts, assessing possible connections to congregate living facilities within its jurisdiction from March 7, 2020, to May 15, 2020, during the first phase of the pandemic, while state of Ohio stay‐at‐home orders were in effect. A multi‐disciplinary team‐based response network was mobilized to support active case finding and develop facility‐focused containment strategies.Results: We identified a cascade of 45 COVID‐19 clusters across community facilities (corrections, nursing, assisted living, intermediate care, extended treatment, shelters, group homes). Attack rates were highest within small facilities (P < .01) and large facilities requiring extensive support to implement effective containment measures. For 25 clusters, we identified an index case who frequently (88%) was a healthcare worker. Engagement of clinical, community, and government partners through public health coordination efforts created opportunities to rapidly develop and coordinate effective response strategies to support the facilities facing the dawning impact of the pandemic.Conclusions: Active cluster investigations can uncover the dynamics of community transmission affecting both residents of congregate settings and their caregivers and help to target efforts toward populations with ongoing challenges in access to detection and control resources.

2 March 2021 in Medical Science Case Reports
Verified
Journal Article
Closed access
PDF file
AFAdeola O. Fakolade
Adeola O. Fakolade
JMJill E. Miracle
Jill E. Miracle
HGHeidi Gullett
Heidi Gullett
PTPauline Terebuh
Pauline Terebuh
AEAmina J. Egwiekhor
Amina J. Egwiekhor
KSKurt C. Stange
Kurt C. Stange
BACKGROUND:Since it was first recognized, Coronavirus Disease 2019 (COVID-19) has become a pandemic, with an estimated 27 million cases and over 800 000 deaths globally. The most common symptoms of the disease are respiratory and constitutional. However, gastrointestinal symptoms (GIS) such as nausea, vomiting, loss of appetite and abdominal pain are also common symptoms in COVID-19, reported in up to 33% of patients. Reports of gastrointestinal bleeding in the literature among SARS-CoV-2-infected patients are limited but increasingly being reported, and the potential mechanism is poorly understood. We present here a series of laboratory confirmed SARS-CoV-2 viral illness with gastrointestinal bleeding (GIB). CASE REPORT:From March 26th, 2020 through May 25th, 2020, we identified 6 patients with lab-confirmed SARS-CoV-2 and GI bleeding episodes. These patients were managed at multiple centers and were identified via mandated reporting of cases to the health department. The age range of these patients was 77 to 102 years old, and the majority had multiple comorbid conditions. The most common presentation was coffee-ground emesis and dark stools. Five of the 6 patients presented from nursing homes and 3 of them died as a result of COVID-19. CONCLUSIONS:GI bleeding is an uncommon and under-appreciated presentation of COVID-19, and clinicians should consider this potential presentation of the disease and implement isolation and treatment protocols early in the course of illness. If an association truly exists, the pathogenesis of GIB in SARS-CoV-2 infection is poorly understood.